Chairman	Michael Sela The Weizmann Institute of Science
	Ruth Arnon The Weizmann Institute of Science
	Haim Aviv Pharmos Ltd.
	Ronit Bendori Evergreen Partners Funds
	Rafi Hofstein Hadasit , Medical Research Services & Development
	Avner Lushi LifeSciences Transaction Support
	Rafi Mechoulam The Hebrew University of Jerusalem
	Avi Molcho Giza Venture Capital
	Arie Moran Ben Gurion University of The Negev
	Aharon Schwartz Teva Pharmaceuticals Ltd.
	Itamar Shalit Schneider Children's Medical Center of Israel
	Isaac Shariv Yeda Research & Development Co. Ltd.
	Claudio Yarza Kesselman & Kesselman
	Yair Amitay MATIMOP - Israeli Industry Center for R&D
	Menachem Leib The Israel Export Institute
	Haya Miller MATIMOP - Israeli Industry Center for R&D
	Ruth Alon Pitango Venture
	Ruth Arnon The Weizmann Institute of Science
	Haim Aviv Pharmos Ltd.
	Avi Barak Yissum, Research & Development
	Ronit Bendori Evergreen Partners Funds
	Avi Berger Kesselman & Kesselman
	Nissim Benvenisty The Hebrew University of Jerusalem
	Yael Biran Minz, Levin, Cohn, Ferris, Glovsky and Popeo P.C.
	Yehudit Birk The Hebrew University of Jerusalem
	Rivka Carmi Ben Gurion University of The Negev
	Shlomo Dagan XTL Biopharmaceuticals
	Eithan Galun Hadassah University Hospital, Jerusalem
	Avri Havron Operon Consultants
	Rafi Hofstein Hadasit, Medical research & development
	Efraim Katzir The Weizmann Institute of Science
	Avner Lushi CEO, Life Sciences Transaction Support (LTS)
	Hanah Margalit The Hebrew University of Jerusalem
	Rafi Mechoulam The Hebrew University of Jerusalem
	Avi Molcho Giza Venture Capital
	Aharon Schwartz Teva Pharmaceuticals Ltd.
	Michael Sela The Weizmann Institute of Science
	Joel Sussman The Weizmann Institute of Science
	Itamar Willner Hebrew University of Jerusalem
	Jeffrey M. Wiesen Mintz, Levin, Cohn, Ferris, Glovsky and Popeo P.C.
	Claudio Yarza Kesselman & Kesselman